Brief: BioSyent Reports Q4 EPS Of C$0.15
09/03/2022 22:37
March 9 (Reuters) - Biosyent Inc RX.V :
* BIOSYENT RELEASES FINANCIAL RESULTS FOR FOURTH QUARTER AND
FULL
YEAR 2021
* Q4 EARNINGS PER SHARE C$0.15
* Q4 REVENUE ROSE 26 PERCENT TO C$7.219 MILLION
Source text for Eikon: ID:nGNX8zL3Mp
Further company coverage: RX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biosyent
See all newsCanada's BioSyent Q2 revenue jumps 95% following Oral Health acquisition
Canada's BioSyent Q1 revenue rises helped by Oral Science acquisition
Brief: Biosyent Announces Closing Of The Acquisition Of Oral Science Inc.
Brief: Biosyent To Acquire Oral Science Inc.
Brief: Biosyent Announces Renewal Of Normal Course Issuer Bid